(S)-(2-METHYLOXIRAN-2-YL)METHYL 4-NITROBENZENESULFONATE, 90.0%, 250mg

tert-Butyl 2-(cyanomethyl)piperazine-1-carboxylate, 98%, 500mg

4-(2-Methoxy-2-oxoethoxy)benzoic acid, 95%, 5g

(R)-1-((Benzyloxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid, 98%, 250mg

Wide mouth bottle, 100 ml, Non-sterile, 335 Piece(s)

2-(1'-(tert-Butoxycarbonyl)spiro[chroman-2,4'-piperidine]-4-yl)acetic acid, 95.0%, 250mg

3-Oxetanone, 95.0%, 10g

3,3'-Oxybis(propan-1-ol), 97%, 1g

2-(chloromethyl)-5-(oxan-4-yl)-1,3,4-oxadiazole, 95.0%, 250mg

4-Chloro-2-[4-(tetrahydro-pyran-4-yl)-piperidin-1-ylmethyl]-phenol, 1g

Manganese(II) sulfate monohydrate, 98.0%, 25g

2-Bromo-1,3-diethylbenzene, 95.0%, 1g

2-Bromo-6-(methoxycarbonyl)benzoic acid, 97.0%, 5g